Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia

Keyphrases

• Dementia Risk 100%
• Secondary Hyperparathyroidism 100%
• CKD-MBD 100%
• Confidence Interval 28%
• Adjusted Hazard Ratio 28%
• End-stage Renal Disease 21%
• Incident Dementia 21%
• Dialysis 14%
• Older Adults 14%
• End-stage Renal Disease Patients 14%
• Old Age 7%
• Low Risk 7%
• Beneficial Effects 7%
• Black Race 7%
• Cox Proportional Hazards Model 7%
• Dementia 7%
• Cognitive Impairment 7%
• Potential Risk Factors 7%
• Multivariable 7%
• Older Patients 7%
• Vitamin D Analogs 7%
• United States Renal Data System (USRDS) 7%
• Dementia Diagnosis 7%
• Diagnostic Codes 7%
• Medicare Claims 7%
• Untreated Patients 7%
• Parathyroidectomy 7%
• Parathyroid Hormone Levels 7%
• Inverse Probability Weighting 7%
• Calcimimetics 7%
• Secondary Injury 7%
• Phosphate Binder 7%
• Time-varying Exposure 7%

Medicine and Dentistry

• Secondary Hyperparathyroidism 100%
• Chronic Kidney Disease-Mineral and Bone Disorder 100%
• End Stage Renal Disease 35%
• Hazard Ratio 28%
• Population 7%
• Proportional Hazards Model 7%
• Parathyroid Hormone 7%
• Cognitive Defect 7%
• Medicare 7%
• Diagnosis Code 7%
• Hormone Determination 7%
• Parathyroidectomy 7%
• Calcimimetic 7%
• Phosphate Binder 7%
• Vitamin D Analog 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Secondary Hyperparathyroidism 100%
• Chronic Kidney Disease-Mineral and Bone Disorder 100%
• End Stage Renal Disease 35%
• Cognitive Defect 7%
• Parathyroid Hormone 7%
• Vitamin D Analog 7%
• Phosphate Binding Agent 7%